Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Schacter

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|February 29, 1980
Elevated superoxide dismutase in black alcoholicsD C Del Villano, S I Miller, L P Schacter, et al.
Seminars in Oncology|December 1, 1990
Overview of hormonal therapy in advanced breast cancerL P Schacter, M Rozencweig, R Canetta, et al.
Cancer|November 15, 1985
Well-differentiated lymphocytic lymphoma with peripheral blood involvement, osteolytic bone lesions, and hypercalcemia. A case report and review of the literatureS L Abboud, V Gordeuk, L P Schacter, et al.
Alcoholism, Clinical and Experimental Research|October 1, 1979
Cupro-zinc superoxide dismutase: a possible biologic marker for alcoholism (studies in black patients)B C Del Villano, J A Tischfield, L P Schacter, et al.
Cancer Research|March 15, 1992
Phase I trial and clinical pharmacology of elsamitrucinM N Raber, R A Newman, B M Newman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Clinical and pharmacokinetic overview of parenteral etoposide phosphateL P Schacter, L N Igwemezie, M Seyedsadr, et al.
The New England Journal of Medicine|May 19, 1988
Anagrelide: a new drug for treating thrombocytosisM N Silverstein, R M Petitt, L A Solberg, et al.
Cancer|July 15, 1982
Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinomaR M Bukowski, L P Schacter, C W Groppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancerN Soni, N J Meropol, L Pendyala, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumorsW Kreis, D R Budman, V Vinciguerra, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|February 29, 1980
Elevated superoxide dismutase in black alcoholicsD C Del Villano, S I Miller, L P Schacter, et al.
Seminars in Oncology|December 1, 1990
Overview of hormonal therapy in advanced breast cancerL P Schacter, M Rozencweig, R Canetta, et al.
Cancer|November 15, 1985
Well-differentiated lymphocytic lymphoma with peripheral blood involvement, osteolytic bone lesions, and hypercalcemia. A case report and review of the literatureS L Abboud, V Gordeuk, L P Schacter, et al.
Alcoholism, Clinical and Experimental Research|October 1, 1979
Cupro-zinc superoxide dismutase: a possible biologic marker for alcoholism (studies in black patients)B C Del Villano, J A Tischfield, L P Schacter, et al.
Cancer Research|March 15, 1992
Phase I trial and clinical pharmacology of elsamitrucinM N Raber, R A Newman, B M Newman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Clinical and pharmacokinetic overview of parenteral etoposide phosphateL P Schacter, L N Igwemezie, M Seyedsadr, et al.
The New England Journal of Medicine|May 19, 1988
Anagrelide: a new drug for treating thrombocytosisM N Silverstein, R M Petitt, L A Solberg, et al.
Cancer|July 15, 1982
Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinomaR M Bukowski, L P Schacter, C W Groppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancerN Soni, N J Meropol, L Pendyala, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumorsW Kreis, D R Budman, V Vinciguerra, et al.
Pageof 3